ReSPECT-GBM Closes Phase 1

by | Jan 14, 2025 | GBM

ReSPECT-GBM Clinical Trial Update: Phase 2 Enrollment Now Open We are excited to announce that enrollment for the Phase 1 ReSPECT-GBM clinical trial is complete! We are actively enrolling patients for Phase 2 of the trial, which focuses on treating recurrent...

Did You Know: LM Fact

by | Jan 10, 2025 | LM

Did You Know? Leptomeningeal Metastases (LM) Rise From Various Cancers Leptomeningeal metastases (LM) is a serious condition where cancer cells spread to the leptomeninges, the membranes that cover the brain and spinal cord. While any cancer can metastasize to the...

ReSPECT-LM Locations

by | Jan 7, 2025 | LM

🚀 Plus Therapeutics Doubles ReSPECT-LM Clinical Trial Locations in 2024 Plus Therapeutics is proud to announce that we have doubled the number of locations for our ReSPECT-LM clinical trial in 2024, expanding to 6 investigation sites nationwide. This significant...

Happy New Year 2025!

by | Jan 2, 2025 | Uncategorized

🎉 Happy New Year from Plus Therapeutics! 🎉 As we ring in the new year, we want to extend our heartfelt gratitude to the patients, medical staff, and the entire cancer community who have supported our mission throughout 2024. Thanks to your dedication and hard work,...

Brains for the Cure

by | Jan 1, 2025 | Uncategorized

ReSPECT Clinical Trials on BrainsFortheCure.org What is Recurrent Glioblastoma (GBM)? Recurrent glioblastoma is a particularly aggressive form of brain cancer that tends to return after initial treatment. GBM recurrence is a major challenge for both patients and...